首页 太平洋生物科学(usPACB)-基本信息

太平洋生物科学(usPACB)-基本信息

日报更新时间:04-10 10:00

周报更新时间:04-11 03:39

行情信息

今开价:33.4

最高价:33.56

成交量:2717737.0

昨收价:33.49

最低价:31.74

最新价:32.16

行情图标
概要信息

中文名称:太平洋生物科学


英文名称:Pacific Biosciences of California


简介:Pacific Biosciences of California, Inc.在2000成立于特拉华州


电话:1-650-5218000


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

Pacific Biosciences of California, Inc.的成立,是建立在康奈尔大学的研究成果上——结合半导体工艺和光子学与生物技术研究,成立之初名为Nanofluidics, Inc.,经过6轮融资,获得4亿美金的风投资金,使公司成为2010年初创公司中的明星企业,同年10月,公司IPO登陆纳斯达克,主要的投资者包括:Mohr Davidow Ventures、Perkins、Wellcome Trust、Kleiner、Caufield & Byers、Alloy Ventures等。加州太平洋生物科学公司主要设计、开发、制造及销售用于基因分析的整合平台,是一家基因测序系统开发和制造公司。Pacific Biosciences of California公司提供单分子实时(SMRT)技术平台,使单分子能够即时侦测生物过程;PacBio RS II高解析度基因分析仪,可即时传导、监测与分析单分子生物化学反应。加州太平洋生物科学公司提供的消耗品部份,包括:密封包装SMRT细胞以及各种试剂套组,如:样品制剂套组、结合试剂套组,以及进行PacBio RS II定序套组等。Pacific Biosciences of California公司的客户包括研究机构、商业实验室、基因体中心、临床、政府与学术机构、基因体学服务提供者、制药公司及农业公司,其产品主要通过直销团队在北美及欧洲销售,亚洲主要为通过经销商销售。

交易日期 交易人 职位 类型 交易份额 价格
2019-03-14 Phillips (James Michael) Officer Buy 7500 --
2019-02-18 Barnes (Susan K) Chief Financial Officer Sell 11987 7.16
2019-02-18 Phillips (James Michael) Officer Sell 7231 7.17
2019-02-18 Ordonez (Kathleen P) Director Sell 6933 7.17
2019-02-18 Hunkapiller (Michael W) Chief Executive Officer Sell 13335 7.19
2019-02-14 Barnes (Susan K) Chief Financial Officer Buy 21250 --
2019-02-14 Ordonez (Kathleen P) Director Buy 19950 --
2019-02-14 Barnes (Susan K) Chief Financial Officer Buy 19950 --
2019-02-14 Hunkapiller (Michael W) Chief Executive Officer Buy 22800 --
2019-02-14 Hunkapiller (Michael W) Chief Executive Officer Buy 38750 --
2019-02-14 Phillips (James Michael) Officer Buy 8000 --
2019-02-14 Phillips (James Michael) Officer Buy 13605 --
2018-12-19 Barnes (Susan K) Chief Financial Officer Buy 18228 2.63
2018-12-19 Barnes (Susan K) Chief Financial Officer Buy 48762 2.27
2018-12-19 Barnes (Susan K) Chief Financial Officer Buy 250000 4.79
2018-11-26 Ordonez (Kathleen P) Officer and Director Buy 25000 2.90
2018-11-26 Ordonez (Kathleen P) Officer and Director Sell 25000 7.54
2018-08-31 Phillips (James Michael) Officer Buy 1 2.01
2018-03-14 Ordonez (Kathleen P) Officer and Director Buy 43750 --
2018-03-14 Hunkapiller (Michael W) Chief Executive Officer Buy 50000 --
2018-03-14 Barnes (Susan K) Chief Financial Officer Buy 43750 --
2018-02-28 Phillips (James Michael) Officer Buy 5989 2.01
2018-02-14 Phillips (James Michael) Officer Buy 15000 --
2017-11-23 Corcoran (Kevin P) Officer Buy 256 1.96
2017-08-31 Phillips (James Michael) Officer Buy 3244 4.07

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Marshall Wace Asset Management Ltd 1914428 1.25% 1294427 208.78% 2019-03-31
Vanguard Investments Australia Ltd 3873183 2.54% -156 -- 2019-07-31
BlackRock Fund Advisors 6063773 3.97% -346615 -5.41% 2019-07-31
Eckert Corp 6072459 3.98% 1814941 42.63% 2019-03-31
Cnh Partners, LLC 6751127 4.42% 166229 2.52% 2019-03-31
Water Island Capital LLC 7247354 4.75% 5882823 431.12% 2019-03-31
Vanguard Group Inc 7611207 4.99% 154082 2.07% 2019-03-31
Magnetar Financial LLC 8217938 5.38% -1064739 -11.47% 2019-03-31
BlackRock Inc 11138603 7.30% -117727 -1.05% 2019-03-31
ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 3383284 2.22% -79008 -2.28% 2019-03-31
ARP AMERICAS LLC 3117632 2.04% 2103200 207.33% 2019-03-31
Gabelli Funds LLC 2900106 1.90% 1155636 66.25% 2019-03-31
LMR Partners LLP 1980650 1.30% 155650 8.53% 2019-03-31
Citigroup Inc 2248523 1.47% 632464 39.14% 2019-03-31
Blackstone Group Inc 2411556 1.58% -- -- 2019-03-31
Citadel Advisors Llc 2646665 1.73% 2626918 13302.87% 2019-03-31
Millennium Management LLC 2730462 1.79% 64374 2.41% 2019-03-31
Northern Trust Investments Inc 2743086 1.80% 40425 1.50% 2019-07-31
State Street Corporation 2759036 1.81% 156705 6.02% 2019-03-31
Goldman Sachs Group Inc 2859483 1.87% 204228 7.69% 2019-03-31
Blackstone Group LP 2411556 1.58% -- -- 2019-03-31
BlackRock Asset Management Canada Ltd 3216337 2.11% -210 -0.01% 2019-05-31
Geode Capital Management, LLC 3146962 2.06% 1729885 122.07% 2018-12-31
Oracle Investment Management Inc 2557764 1.68% -6829870 -72.75% 2018-12-31
UBS Group AG 1919173 1.26% 1428246 290.93% 2018-12-31
Capital Research & Mgmt Co - Division 3 2080000 1.36% -2082441 -50.03% 2018-12-31
Consonance Capital Management LP 2455114 1.61% -11057844 -81.83% 2018-12-31
D. E. Shaw & Co LP 2099833 1.38% 1837321 699.90% 2018-12-31
Capital Research and Management Company 2080000 1.38% -6763303 -76.48% 2019-03-31
Bellevue Group AG 2575000 1.71% 2575000 -- 2018-09-30
Broadfin Capital, LLC 2493021 1.65% 1438930 136.51% 2018-09-30
Northern Trust Corp 1526320 1.02% 63090 4.31% 2018-09-30
Federated Investors Inc 1600000 1.07% 1600000 -- 2018-09-30
RTW INVESTMENTS, LLC 2237607 1.50% 2237607 -- 2018-09-30
Capital World Investors 4680862 3.13% -4696594 -50.08% 2018-09-30
Point72 Asset Management, L.P. 5175000 3.47% 2275000 78.45% 2018-09-30
ARK Investment Management LLC 7786485 5.21% 1465192 23.18% 2018-09-30
Maverick Capital Ltd 12173094 8.15% -- -- 2018-09-30
Larry N Feinberg 4892337 3.28% -624557 -11.32% 2017-12-31
Federated Global Inv Mgmt Corp 1600000 1.07% 1600000 -- 2018-09-30
Invesco Advisers, Inc. 1966580 1.32% -27925 -1.40% 2018-11-30
BlackRock Institutional Trust Company NA 3080389 2.07% -16418 -0.53% 2018-06-30
Federated Equity Mgmt Co. Of Penn 1600000 1.07% 1600000 -- 2018-11-30
Raging Capital Management LLC 3316614 2.23% 125519 3.93% 2018-03-31
Northern Trust Investments N A 1463230 0.98% 140090 10.59% 2018-06-30
Charles Schwab Investment Management Inc 614288 0.47% 95551 18.42% 2018-06-30
Arrowpoint Asset Management, LLC 4507794 3.42% -258618 -5.43% 2018-06-30
Seventh MDV Partners, LLC 5598397 4.81% -- -- 2017-12-31
Invesco Ltd 4176951 3.59% -1146255 -21.53% 2017-12-29
State Street Corp 2247341 1.70% 354804 18.75% 2018-06-30
Frontier Capital Management CO Inc 1429505 1.08% -23198 -1.60% 2018-06-30
Trellus Management Company, LLC 700000 0.53% -75000 -9.68% 2018-06-30
BNY Mellon Investment Management 319608 0.24% 39768 14.21% 2018-06-30
Teachers Advisors Inc 1029585 0.78% -- -- 2018-03-31
Mutual Of America Capital Management LLC 510472 0.44% 28384 5.89% 2017-12-31
Foresite Capital Management III, LLC 447520 0.38% -702480 -61.09% 2017-12-31
Invesco Advisers, Inc 4125123 3.55% -1007770 -19.63% 2017-12-31
California Public Employees Retrmnt Sys 457400 0.39% -- -- 2017-09-30
NORTH TIDE CAPITAL LLC 1000000 0.86% 1000000 -- 2017-09-30
Lord, Abbett & Co LLC 814484 0.70% 221473 37.35% 2017-09-30
Soros Fund Management LLC 670400 0.58% 670400 -- 2017-09-30
BlackRock Advisors LLC 586306 0.50% -342378 -36.87% 2017-11-30
Bridger Management LLC 4964123 5.36% -218116 -4.21% 2016-09-30
KPCB XI ASSOCIATES, LLC 1522576 1.90% -1794800 -54.10% 2015-12-31
Peregrine Capital Management Inc 974505 1.05% 974505 -- 2016-09-30
Ghost Tree Capital, LLC 750000 0.81% 750000 -- 2016-09-30
Brook Byers 3696654 2.00% 23288920 -- 1999-11-30
Michael Hunkapiller, Ph.D. 4437246 2.00% 27954650 0.10% 1999-11-30
Entities affiliated with Deerfield Management Company, L.P. 5120771 2.00% 32260857 0.10% 1999-11-30
William Ericson 5598397 2.00% 35269901 0.10% 1999-11-30
Entities affiliated with Maverick Capital Ltd. 6459784 2.00% 40696639 0.10% 1999-11-30
BlackRock Inc. 7382305 2.00% 46508522 0.10% 1999-11-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
Gabelli ABC Fund 1058700 0.69% 258700 32.34% 2019-03-31
Vanguard Total Stock Market Index Fund 3846277 2.51% -- -- 2019-06-30
iShares Russell 2000 ETF 3105441 2.03% 6083 0.20% 2019-07-30
Meridian Small Cap Growth Fund 2098993 1.37% -- -- 2019-03-31
Arbitrage Fund 2012969 1.32% 610956 43.58% 2019-05-31
Vanguard Extended Market Index Fund 1916461 1.25% 4300 0.22% 2019-06-30
IQ Merger Arbitrage ETF 1654931 1.08% -- -- 2019-07-31
iShares Nasdaq Biotechnology ETF 1507141 0.99% 15599 1.05% 2019-07-30
iShares Russell 2000 Growth ETF 1196607 0.78% 17740 1.50% 2019-07-30
Litman Gregory Masters Alt Strats Fund 1019185 0.67% 68902 7.25% 2019-06-30
Gabelli Entpr Mergers and AcquisitionsFd 435000 0.28% -- -- 2019-04-30
GDL Fund 450000 0.29% 240000 114.29% 2019-03-31
NT R2000 Index Fund - NL 531074 0.35% 7633 1.46% 2019-06-30
Fidelity 557810 0.36% 69853 14.32% 2019-04-30
State Street Russell Small Cap 572865 0.37% -- -- 2019-06-30
NT R2000 Growth Index Fund - Non-Lending 581750 0.38% -15677 -2.62% 2019-06-30
State Street Russell Small/Mid Cap 588114 0.38% -- -- 2019-06-30
iShares Healthcare Innov ETF 592172 0.39% -- -- 2019-07-30
Vanguard Alternative Strategies Fund 600000 0.39% -- -- 2019-03-31
Pictet TR - Divers Alpha 1034138 0.68% 647553 167.51% 2019-05-31
NT R2000 Growth Index Fund - Lending 412974 0.27% 10996 2.74% 2019-03-31
iShares US Small Cap ETF (CAD-Hedged) 2841593 1.86% -4770 -0.17% 2019-05-30
Vivaldi Merger Arbitrage Fund 494620 0.32% 494620 -- 2018-12-31
American Funds SMALLCAP World Fund 2080000 1.38% -6763303 -76.48% 2018-12-31
1290 VT GAMCO Mergers & Acquisitions Ptf 384011 0.25% 84011 28.00% 2019-01-31
Schwab US Small-Cap ETF 392885 0.26% -- -- 2019-03-29
Allianz Merger Arbitrage Strategy 397147 0.26% -- -- 2019-01-31
Vanguard Health Care Index Fund 358722 0.24% 22380 6.65% 2019-02-28
Mutual of America Small Cap Value Fund 355157 0.24% -27404 -7.16% 2018-09-30
Oppenheimer Global Multi-Alts Fd/VA 342696 0.23% -- -- 2019-01-31
iShares Micro-Cap ETF 335295 0.22% -- -- 2019-02-28
VA CollegeAmerica SMALLCAP Wld Fd 2080000 1.38% -6763303 -76.48% 2018-12-31
Franklin K2 Alternative Strategies Fund 278807 0.19% -- -- 2018-12-31
Bridgeway Ultra Small Company Market Fd 320200 0.21% -- -- 2018-09-30
Schwab Small Cap Index Fund 263830 0.18% 29330 12.51% 2018-12-31
Victory RS Science and Technology Fund 300000 0.20% 300000 -- 2018-09-30
Federated Kaufmann Small Cap Fund 1600000 1.07% 1600000 -- 2018-09-30
OMI IM USD Franklin K2 Alt Strats 278807 0.19% 278807 -- 2018-11-30
ArrowMark Small Cap Growth UCITS Fd 201900 0.14% -- -- 2018-11-30
The Vanguard - Russell 2000 Grwth Idx CF 217130 0.15% -506 -0.23% 2018-11-30
ARK Innovation ETF 4219324 2.83% -80020 -1.86% 2018-10-31
ARK Genomic Revolution Multi-Sector ETF 3308009 2.22% 27411 0.84% 2018-10-31
TIAA-CREF Quant Small-Cap Equity Fund 831700 0.56% -- -- 2018-04-30
BlackRock Advantage US Total Market Fund 569285 0.38% -25548 -4.29% 2017-09-30
BrighthouseI Invesco Small Cap Gr Port 824257 0.55% -91208 -9.96% 2017-12-31
Meridian Contrarian Fund 1142477 0.77% -130000 -10.22% 2017-09-30
JNL/Invesco Small Cap Growth Fund 1226249 0.82% -66787 -5.17% 2017-12-31
Invesco Small Cap Growth Fund 1879430 1.26% -115075 -5.77% 2017-12-31
Fidelity Spartan 502855 0.38% -- -- 2018-07-31
iShares Russell 2000 Growth 1180329 0.87% -1138 -0.10% 2018-09-12
Vanguard Extended Market Idx Inv 1513105 1.15% -- -- 2018-07-31
iShares Nasdaq Biotechnology 1502139 1.11% -2859 -0.19% 2018-09-12
Meridian Small Cap Growth Investor 2527597 1.92% -59192 -2.29% 2018-06-30
Vanguard Total Stock Mkt Idx 3334838 2.53% -- -- 2018-07-31
VA CollegeAmerica Smcap World 529E 9377456 7.11% -920621 -8.94% 2018-06-30
Bridgeway Ultra-Small Company Market 320200 0.24% 145200 82.97% 2018-06-30
iShares Micro-Cap 321916 0.24% -- -- 2018-09-12
Northern Trust Russell 2000 Index Fund - DC - Non-Lending 295117 0.22% -136 -0.05% 2018-07-31
CREF Stock R1 258916 0.20% -5406 -2.05% 2018-07-31
State Street Russell Small/Mid Cap Idx Fd Cl I 275713 0.24% 32215 13.23% 2017-06-30
SEI Small Cap Growth A (SIMT) 187144 0.14% -30000 -13.82% 2018-08-31
Vanguard Health Care ETF 244804 0.19% 2072 0.85% 2018-07-31
Schwab Small Cap Index 234500 0.18% 19200 8.92% 2018-07-31
The Vanguard Russell 2000 Growth Index 221356 0.17% 5710 2.65% 2018-07-31
Mutual of America Small Cap Value 382561 0.29% -- -- 2018-03-31
BlackRock Extended Equity Market K 218113 0.17% 80221 58.18% 2018-06-30
Vanguard Instl Ttl Stk Mkt Idx InstlPls 193040 0.15% 31046 19.16% 2018-06-30
BlackRock Russell 2000 172223 0.13% 18801 12.25% 2018-06-30
TIAA-CREF Small-Cap Equity Instl 831700 0.63% -- -- 2018-04-30
JNL/Invesco Small Cap Growth B 1226249 1.05% -66787 -5.17% 2017-12-31
Met Invt Ser Invesco Small Cap Gr A 824257 0.71% -91208 -9.96% 2017-12-31
Invesco Small Cap Growth A 1879430 1.62% -115075 -5.77% 2017-12-31
BlackRock Value Opportunities Instl 569285 0.49% -25548 -4.29% 2017-09-30
Lord Abbett Micro Cap Growth I 191873 0.17% -2241 -1.15% 2017-11-30
Meridian Contrarian Legacy 1142477 0.98% -130000 -10.22% 2017-09-30
Pru Ret SA/Invesco Small Cap Gr Strat SP 139626 0.12% 3174 2.33% 2017-09-30
Strategic Advisers 489075 0.42% 8095 1.68% 2017-08-31
BlackRock Master Value Opportunities LLC 303346 0.26% -15925 -4.99% 2017-11-30
BlackRock Global SmallCap Inv A 316830 0.27% -242880 -43.39% 2017-10-31
AXA/Lord Abbett Micro Cap K 178463 0.19% -- -- 2016-11-30
Lord Abbett Developing Growth A 1135128 1.22% -1973965 -63.49% 2016-12-31
Mutual of America Small Cap Growth 168161 0.18% 33890 25.24% 2016-09-30
VP Partners Small Cap Growth 2 455803 0.49% 153347 50.70% 2016-12-31
Lord Abbett Growth Leaders A 294004 0.32% -433806 -59.60% 2016-12-31
AMG Managers Emerging Opps Svc 112153 0.12% 17359 18.31% 2016-10-31
BlackRock Glb Global SmallCap Fund 419402 0.60% -27829 -6.20% 2015-07-31
Fidelity Spartan® Extended Mkt Indx Fd 246585 0.30% -- -- 2015-09-30
BlackRock Value Opportunities V.I. Fund 175870 0.20% 9752 5.90% 2015-10-31
Mutual of America Small Cap Growth Fund 168351 0.20% -- -- 2015-06-30
BlackRock Global Small Cap Fund 144246 0.20% -11720 -7.50% 2015-10-31
iShares Russell 2000 (AU) 960756 1.80% -1212 -0.10% 2015-11-19
CREF Stock Account 166732 0.20% -- -- 2015-09-30

John F. Milligan John F. Milligan is on the board of Pacific Biosciences of California, Inc., Biotechnology Innovation Organization and Ohio Wesleyan University. Dr. Milligan previously held the position of President, Chief Executive Officer & Director at Gilead Sciences, Inc. and President at Pharmasset, Inc. (a subsidiary of Gilead Sciences, Inc.) and Director-Project Management at Hoffmann-La Roche, Inc. Dr. Milligan received a doctorate from the University of Illinois and an undergraduate degree from Ohio Wesleyan University.
Marshall L. Mohr Presently, Marshall L. Mohr holds the position of Chief Financial Officer & Executive Vice President of Intuitive Surgical, Inc. He is also on the board of Plantronics, Inc., Pacific Biosciences of California, Inc. and Intuitive Surgical Ltd. In his past career Marshall L. Mohr occupied the position of Chief Financial Officer & Vice President for Adaptec, Inc. and Managing Partner at PricewaterhouseCoopers LLP. Mr. Mohr received an undergraduate degree from Western Michigan University.
Christian O. Henry Currently, Christian O. Henry is Chairman for Wave Life Sciences Ltd. Mr. Henry is also on the board of Pacific Biosciences of California, Inc. In his past career he held the position of Vice President-Finance & Controller at Nektar Therapeutics, Chief Commercial Officer & Executive VP for Illumina, Inc., Vice President-Finance & Controller at Affymetrix, Inc., Chief Financial Officer of Tickets.com, Inc., Senior Vice President & General Manager at Genomic Solutions, Inc., General Accounting Manager at Sugen LLC and Senior Accountant at Ernst & Young LLP. Mr. Henry received an undergraduate degree from the University of California San Diego and an MBA from the University of California, Irvine.
Kevin P. Corcoran Kevin P. Corcoran is Senior Vice President-Market Development at Pacific Biosciences of California, Inc. He previously occupied the position of President & Chief Executive Officer at Lynx Therapeutics, Inc. and Vice President & GM-DNA Sequencing Business at Applied Biosystems, Inc. Kevin P. Corcoran received an undergraduate degree from California State University-East Bay.
Michael W. Hunkapiller Michael W. Hunkapiller founded Celera Group. Currently, he holds the position of Executive Chairman, President & CEO at Pacific Biosciences of California, Inc. and General Partner of Alloy Ventures, Inc. Dr. Hunkapiller is also on the board of NuGEN Technologies, Inc., Verinata Health, Inc. and RainDance Technologies, Inc. and Member of National Academy of Engineering. Michael W. Hunkapiller previously occupied the position of President & General Manager at Applied Biosystems, Inc. and Senior Vice President for Applera Corp. Dr. Hunkapiller received an undergraduate degree from Oklahoma Baptist University and a doctorate from California Institute of Technology.
Brook H. Byers Dr. Stephen W. Turner is Chief Technical Officer & Vice President at Pacific Biosciences of California, Inc. and a Member of National Institutes of Health. He received his undergraduate degree from the University of Wisconsin and a doctorate degree from Cornell University.
Susan K. Barnes Currently, Susan K. Barnes is CFO, Principal Accounting Officer & Senior VP at Pacific Biosciences of California, Inc. She is also on the board of The Nueva School. In the past Ms. Barnes was Managing Director at Blum Capital Partners LP and Chief Financial Officer & Managing Director at Richard C. Blum & Associates LP (a subsidiary of Blum Capital Partners LP), Chief Financial Officer & Senior VP-Finance at Intuitive Surgical, Inc., Controller-Macintosh Division at Apple, Inc. and Chief Financial Officer & Vice President of NeXt Software, Inc. (a subsidiary of Apple, Inc.) and Managing Director-Private Equity Group at Jefferies LLC. She received an undergraduate degree from Bryn Mawr College and an MBA from The Wharton School of the University of Pennsylvania.
Randall S. Livingston Randall S. Livingston is Chief Financial Officer & VP-Business Affairs at Stanford University and on the board of 5 other companies. He previously held the position of Director-Corporate Development at Apple, Inc., CFO, Director & Executive Vice President at OpenTV, Inc. and Chief Financial Officer of Taligent, Inc. Mr. Livingston received an undergraduate degree and an MBA from Stanford University and an MBA from Stanford Graduate School of Business.
Lucy Shapiro Founder of Anacor Pharmaceuticals, Inc. and Boragen, Inc., Lucy Shapiro occupies the position of Director & Professor at Beckman Center for Molecular & Genetic Medicine. She is also on the board of Pacific Biosciences of California, Inc. and Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of Institute of Medicine, Member of American Academy of Microbiology, Professor at Stanford University School of Medicine and Professor at The Cancer Research Foundation. In her past career Dr. Shapiro held the position of Scientific Advisor at Hatteras Venture Partners, Chairman-Microbiology & Immunology Department at College of Physicians & Surgeons of BC and Independent Director at Anacor Pharmaceuticals, Inc. Lucy Shapiro received an undergraduate degree from Brooklyn College and a doctorate from Albert Einstein College of Medicine, Inc.
William W. Ericson William W. Ericson founded Venture Law Group LLP. Currently, Mr. Ericson is General Partner of MDV Management Co. LLC. Mr. Ericson is also Member of Personalized Medicine Coalition and Founding Partner of Wildcat Venture Partners LLC and on the board of 10 other companies. He received a graduate degree from Northwestern University School of Law, an undergraduate degree from Edmund A. Walsh School of Foreign Service and an undergraduate degree from Georgetown University School of Foreign Service In Qatar.
Kathy P. Ordo�0�1±ez Kathy P. Ordo�0�1±ez is a businessperson who founded Celera Diagnostics LLC and who has been the head of 6 different companies. She is on the board of Quidel Corp., Pacific Biosciences of California, Inc. and Advanced Medical Technology Association. In the past Ms. Ordo�0�1±ez held the position of President of Celera Diagnostics LLC, Senior Vice President-Diagnostic Solutions at Quest Diagnostics, Inc. President & Chief Executive Officer at Celera Corp. and President of Celera Group (both are subsidiaries of Quest Diagnostics, Inc.), Non-Executive Chairman & Chief Executive Officer at RainDance Technologies, Inc., President & Chief Executive Officer for Roche Molecular Systems, Inc., President at Roche Diagnostics Corp., Principal at Hoffmann-La Roche, Inc. and Senior Vice President at Applera Corp. She received an MBA from Pace University and an undergraduate degree from Hartwick College.
Stephen W. Turner Founder of Pacific Biosciences of California, Inc., Stephen W. Turner is Chief Technology Officer at this company. He is also Member of National Institutes of Health. Dr. Turner received a doctorate from Cornell University and an undergraduate degree from the University of Wisconsin.
Stephen M. Moore Currently, Stephen M. Moore holds the position of Secretary, Vice President & General Counsel for Pacific Biosciences of California, Inc. He previously held the position of General Counsel for Life Technologies Clinical Services Lab, Inc. and General Counsel of Affymetrix, Inc. Mr. Moore received a graduate degree from the University of California, Davis.
James Michael Phillips Presently, James Michael Phillips occupies the position of Senior Vice President-Research & Development at Pacific Biosciences of California, Inc. In his past career he occupied the position of Principal at Hyland Laboratories, Inc., Director-Research & Development at Applied Biosystems, Inc. and Principal at National Marine Fisheries Service. He received an undergraduate degree from the University of California, Davis.
David Botstein Currently, David Botstein is Chief Scientific Officer of Calico LLC. He is also on the board of Pacific Biosciences of California, Inc. and Impossible Foods, Inc. and Member of Institute of Medicine, Member of National Academy of Sciences and Professor-Emeritus at Princeton University. He previously occupied the position of Vice President-Science at Genentech, Inc. and Chairman-Genetics Department at Stanford University. David Botstein received a doctorate from the University of Michigan and an undergraduate degree from Harvard University.
Trevin Rard Currently, Trevin Rard is Head-Investor Relations of Pacific Biosciences of California, Inc.
Trevin Rard Currently, Trevin Rard is Head-Investor Relations of Pacific Biosciences of California, Inc.
Jonas Korlach Jonas Korlach holds the position of Chief Scientific Officer for Pacific Biosciences of California, Inc. Dr. Korlach received a doctorate and a graduate degree from Cornell University and a graduate degree and an undergraduate degree from Humboldt-Universit�0�1¤t zu Berlin.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐